These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 18073512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].
    Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C.
    Rev Neurol; ; 43(9):541-8. PubMed ID: 17072810
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
    Cabral GA, Marciano-Cabral F.
    J Leukoc Biol; 2005 Dec; 78(6):1192-7. PubMed ID: 16204639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cannabinoid influence on cytokine profile in multiple sclerosis.
    Katona S, Kaminski E, Sanders H, Zajicek J.
    Clin Exp Immunol; 2005 Jun; 140(3):580-5. PubMed ID: 15932522
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
    Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A.
    Glia; 2003 Jan 15; 41(2):161-8. PubMed ID: 12509806
    [Abstract] [Full Text] [Related]

  • 7. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
    Correa F, Mestre L, Molina-Holgado E, Arévalo-Martín A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C.
    Mini Rev Med Chem; 2005 Jul 15; 5(7):671-5. PubMed ID: 16026313
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.
    Tolón RM, Núñez E, Pazos MR, Benito C, Castillo AI, Martínez-Orgado JA, Romero J.
    Brain Res; 2009 Aug 04; 1283():148-54. PubMed ID: 19505450
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
    O'Sullivan SE, Kendall DA.
    Immunobiology; 2010 Aug 04; 215(8):611-6. PubMed ID: 19833407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
    Croxford JL, Yamamura T.
    J Neuroimmunol; 2005 Sep 04; 166(1-2):3-18. PubMed ID: 16023222
    [Abstract] [Full Text] [Related]

  • 17. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K, Goś R.
    Klin Oczna; 2008 Sep 04; 110(10-12):392-6. PubMed ID: 19195174
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS, Sim-Selley LJ.
    Int Rev Psychiatry; 2009 Apr 04; 21(2):113-21. PubMed ID: 19367505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.